2-[(3R,4S,8S,9S,10S,11R,13R,14S,16S)-16-ACETOXY-3,11-DIHYDROXY-4,8,10,14-TETRAMETHYL-HEXADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-(17E)-YLIDENE]-6-METHYL-HEPT-5-ENOIC ACID

2-[(3R,4S,8S,9S,10S,11R,13R,14S,16S)-16-ACETOXY-3,11-DIHYDROXY-4,8,10,14-TETRAMETHYL-HEXADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-(17E)-YLIDENE]-6-METHYL-HEPT-5-ENOIC ACID Struktur
CAS-Nr.
Englisch Name:
2-[(3R,4S,8S,9S,10S,11R,13R,14S,16S)-16-ACETOXY-3,11-DIHYDROXY-4,8,10,14-TETRAMETHYL-HEXADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-(17E)-YLIDENE]-6-METHYL-HEPT-5-ENOIC ACID
Synonyma:
2-[(3R,4S,8S,9S,10S,11R,13R,14S,16S)-16-ACETOXY-3,11-DIHYDROXY-4,8,10,14-TETRAMETHYL-HEXADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-(17E)-YLIDENE]-6-METHYL-HEPT-5-ENOIC ACID
CBNumber:
CB0812847
Summenformel:
C31H48O6
Molgewicht:
516.70922
MOL-Datei:
Mol file

2-[(3R,4S,8S,9S,10S,11R,13R,14S,16S)-16-ACETOXY-3,11-DIHYDROXY-4,8,10,14-TETRAMETHYL-HEXADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-(17E)-YLIDENE]-6-METHYL-HEPT-5-ENOIC ACID Eigenschaften

Sicherheit

2-[(3R,4S,8S,9S,10S,11R,13R,14S,16S)-16-ACETOXY-3,11-DIHYDROXY-4,8,10,14-TETRAMETHYL-HEXADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-(17E)-YLIDENE]-6-METHYL-HEPT-5-ENOIC ACID Chemische Eigenschaften,Einsatz,Produktion Methoden

2-[(3R,4S,8S,9S,10S,11R,13R,14S,16S)-16-ACETOXY-3,11-DIHYDROXY-4,8,10,14-TETRAMETHYL-HEXADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-(17E)-YLIDENE]-6-METHYL-HEPT-5-ENOIC ACID Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


2-[(3R,4S,8S,9S,10S,11R,13R,14S,16S)-16-ACETOXY-3,11-DIHYDROXY-4,8,10,14-TETRAMETHYL-HEXADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-(17E)-YLIDENE]-6-METHYL-HEPT-5-ENOIC ACID Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Zerenex Molecular Limited --
sales@zerenex-molecular.com United Kingdom 6205 47

  • 2-[(3R,4S,8S,9S,10S,11R,13R,14S,16S)-16-ACETOXY-3,11-DIHYDROXY-4,8,10,14-TETRAMETHYL-HEXADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-(17E)-YLIDENE]-6-METHYL-HEPT-5-ENOIC ACID
Copyright 2019 © ChemicalBook. All rights reserved